Page last updated: 2024-08-22

helenalin and 11alpha,13-dihydrohelenalin

helenalin has been researched along with 11alpha,13-dihydrohelenalin in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19903 (42.86)18.7374
1990's1 (14.29)18.2507
2000's2 (28.57)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hall, IH; Ibuka, T; Lee, KH; Mar, EC1
Hall, IH; Lee, KH; Mar, EC; Starnes, CO; Waddell, TG1
Hall, IH; Ibuka, T; Kim, HL; Kiyokawa, H; Lee, KH; Muraoka, O; Sims, D1
Beekman, AC; Konings, AW; Pras, N; Schmidt, TJ; van Uden, W; Wikström, HV; Woerdenbag, HJ1
Castro, V; Da Costa, FB; García-Piñeres, AJ; Kisiel, W; Klaas, CA; Merfort, I; Murillo, R; Rüngeler, P; Schulte-Mönting, J; Siedle, B1
Gasteiger, J; Hofmann, A; Merfort, I; Siedle, B; Terfloth, L; Wagner, S1
Lee, KH1

Reviews

1 review(s) available for helenalin and 11alpha,13-dihydrohelenalin

ArticleYear
Discovery and development of natural product-derived chemotherapeutic agents based on a medicinal chemistry approach.
    Journal of natural products, 2010, Mar-26, Volume: 73, Issue:3

    Topics: Anti-HIV Agents; Biological Factors; Drug Design; Molecular Structure; Pharmaceutical Preparations; Plants, Medicinal

2010

Other Studies

6 other study(ies) available for helenalin and 11alpha,13-dihydrohelenalin

ArticleYear
Antitumor agents. 31. Helenalin sym-dimethylethylenediamine reaction products and related derivatives.
    Journal of medicinal chemistry, 1978, Volume: 21, Issue:7

    Topics: Alkylating Agents; Animals; Carcinoma 256, Walker; Cells, Cultured; Chemical Phenomena; Chemistry; Ethylenediamines; Lactams; Leukemia, Experimental; Male; Mice; Rats; Sesquiterpenes; Sesquiterpenes, Guaiane

1978
Antitumor agents. 21. A proposed mechanism for inhibition of cancer growth by tenulin and helenalin and related cyclopentenones.
    Journal of medicinal chemistry, 1977, Volume: 20, Issue:3

    Topics: Animals; Antineoplastic Agents, Phytogenic; Ascitic Fluid; Carcinoma 256, Walker; Carcinoma, Ehrlich Tumor; Chromatin; Cyclopentanes; Cysteine; DNA, Neoplasm; Glutathione; Histidine; Lactones; Leukemia, Experimental; Leukemia, Lymphoid; Male; Mice; Mice, Inbred DBA; Neoplasm Proteins; Rats; Sesquiterpenes; Sesquiterpenes, Guaiane; Spectrophotometry, Ultraviolet; Time Factors

1977
Antitumor agents. 44. Bis(helenalinyl) esters and related derivatives as novel potent antileukemic agents.
    Journal of medicinal chemistry, 1981, Volume: 24, Issue:8

    Topics: Animals; Antineoplastic Agents, Phytogenic; Drug Evaluation; Leukemia, Experimental; Mice; Sesquiterpenes; Structure-Activity Relationship

1981
Structure-cytotoxicity relationships of some helenanolide-type sesquiterpene lactones.
    Journal of natural products, 1997, Volume: 60, Issue:3

    Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Ehrlich Tumor; Chromatography, High Pressure Liquid; Computer Simulation; Drug Screening Assays, Antitumor; Lactones; Mice; Models, Structural; Molecular Conformation; Sesquiterpenes; Structure-Activity Relationship; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured

1997
Quantitative structure-activity relationship of sesquiterpene lactones as inhibitors of the transcription factor NF-kappaB.
    Journal of medicinal chemistry, 2004, Nov-18, Volume: 47, Issue:24

    Topics: Electrophoretic Mobility Shift Assay; Humans; Jurkat Cells; Lactones; Models, Molecular; NF-kappa B; Quantitative Structure-Activity Relationship; Regression Analysis; Sesquiterpenes

2004
Development of a structural model for NF-kappaB inhibition of sesquiterpene lactones using self-organizing neural networks.
    Journal of medicinal chemistry, 2006, Apr-06, Volume: 49, Issue:7

    Topics: Lactones; Models, Molecular; Neural Networks, Computer; NF-kappa B; Quantitative Structure-Activity Relationship; Sesquiterpenes

2006